PPARG and asthma: It is critical to extend these comparisons to cells derived from asthmatics where the ability of corticosteroids to inhibit proliferation is reduced [77] to determine whether PPARγ provides an additional or alternative therapeutic target to glucocorticoid receptors to regulate remodelling in asthma.